Category Archives: Cardiovascular

Angela Conley thought it was just a pulled muscle, probably from shoveling January snow. But as the pain between her shoulder blades persisted and her jaw started to hurt, Conley sensed something was wrong and reluctantly called 911. “I’ll never forget that day,” the Hennepin County commissioner said recently in her downtown Minneapolis office. That […]

Choosing the stairs over the elevator has been considered sage fitness advice for years, but a new study published proves backs up this health tip in the journal Atherosclerosis looked at exactly how many flights of stairs you need to climb daily to better your heart health. The short answer? Climbing just five flights per […]

Following the initial top-line readout in August – which showed a statistically significant, 20% relative risk reduction in MACE-3 cardiovascular events – the veil has finally been lifted from the landmark SELECT cardiovascular outcomes trial. Novo Nordisk shared further details in its much anticipated presentation of the full data from SELECT at the American Heart […]

November 11, 2023 4 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . <button type="button" class="btn btn-primary" data-loading-text="Loading ” data-action=”subscribe”> Subscribe Added to email alerts We were unable to process your request. […]

PHILADELPHIA — An enormous swath of Americans can be expected to get secondary cardiovascular prevention benefits from weekly semaglutide (Wegovy) injections based on the SELECT trial. Even in the absence of diabetes, overweight and obese people with pre-existing cardiovascular disease had the advantage of a substantially lower incidence of combined death from cardiovascular causes, myocardial […]

The weight-loss drug Wegovy reduces the risk of experiencing or dying from events like heart attacks and strokes by 20 percent in people with obesity and preexisting heart disease, according to results from a late-stage clinical trial published in The New England Journal of Medicine. For the study, scientists randomly assigned 17,604 people with obesity […]

November 10, 2023 — Silence Therapeutics plc, an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, announced positive topline results from the multiple dose component of the APOLLO phase 1 study of zerlasiran (formerly SLN360) in 36 adults with baseline lipoprotein(a), or Lp(a), levels at or over 150 […]

The American Heart Association is meeting in Philadelphia this weekend for its international scientific session, so cardiovascular health is all over the news. This week’s health briefs focus on two things you should know to keep your heart and that of those you love healthy. Cardiologists release new heart disease risk calculator The new trademarked […]

PREVENT risk calculator designed for adults as young as 30 AHA’s previous CVD risk calculator was developed with 10-year risks among patients 40 to 79 years old. PREVENT, however, can determine a patient’s 10- or 30-year risk to maximize its ability make an impact. In addition, the team behind PREVENT wanted it to offer value […]

A new calculator estimates a person’s risk for cardiovascular disease (CVD) over the next 30 years by combining measures of cardiovascular, kidney and metabolic health for the first time, according to a new American Heart Association Scientific Statement published today in the Association’s flagship journal Circulation. An accompanying methods paper, published simultaneously today in Circulation, […]